Literature DB >> 6708496

Bile acid-induced gastric mucosal injury: significance of portal hypertension and mucosal capillary permeability.

R Maeda, E Guilmette, A Tarnawski, I J Sarfeh.   

Abstract

Rats with portal vein occlusion (PVO) were studied to determine severity of taurocholate-induced gastric mucosal injury during portal hypertension and following its resolution by collaterals. During the portal hypertensive state, after intragastric taurocholate, PVO rats compared with sham-operated controls had significantly greater macroscopic damage (14 +/- 1 vs 3 +/- 1% of total mucosa) and histologic deep necrosis (25 +/- 4 vs 3 +/- 1% of mucosal length). Gastric mucosal capillary permeability was also significantly greater in PVO rats, as assessed by increased appearance of intravenous Evans blue dye in gastric wall and contents. After 21 days of PVO portal pressures returned to normal. At this time taurocholate-induced gastric mucosal damage and capillary leak became similar in PVO and sham-operated rats. It is concluded that the portal hypertensive state alone predisposes to severe gastric mucosal damage and capillary leak.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6708496     DOI: 10.1016/0022-4804(84)90105-7

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  3 in total

1.  Impaired oxygenation of gastric mucosa in portal hypertension. The basis for increased susceptibility to injury.

Authors:  I J Sarfeh; H Soliman; K Waxman; M Coccia; E B Rypins; H X Bui; A Tarnawski
Journal:  Dig Dis Sci       Date:  1989-02       Impact factor: 3.199

2.  Taurocholate induced gastric mucosal injuries in experimental portal hypertension.

Authors:  W J Angerson; J G Geraghty; D C Carter
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

3.  Propranolol reduces ethanol-induced gastric mucosal damage in portal hypertensive rats.

Authors:  H Sankary; I J Sarfeh; A Tarnawski; R Maeda; K J Ivey; G R Mason
Journal:  Dig Dis Sci       Date:  1986-02       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.